Skip to Main Content

Paper Details

Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer.
Clin Cancer Res
3
2023
Bladder Cancer, DNA damage response gene, ERCC2, ERCC2 mutant, ERCC2 mutant bladder cancer cell lines, ERCC2 mutation, MIBC, TMT, cancer, cisplatin, isogenic ERCC2 wildtype cells, muscle-invasive bladder cancer, patients, tumors
Author NameAffiliation
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenDana-Farber Cancer Institute
Yang LiuVeracyte inc.
Elai Davicioni
David T MiyamotoMassachusetts General Hospital
  • 1 - 5

Datasets

Release 1.2